Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seltorexant driving performance study
NCT02578472Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of seltorexant in Insomnia (6 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Standard Deviation of Lateral Position at 8 hours. Started Nov 2015; status: completed.
02
Drugs
seltorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02578472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578472.